WELFARE, Medicaid

Select or search for a subject in the dropdown list above to view associated bills for that subject

Name Description Status
HB 1146 Nonaddictive substance abuse drugs and Medicaid. (H) First reading: referred to Committee on Public Health 1146
SB 444 Telemedicine. (S) First reading: referred to Committee on Health and Provider Services 444
SB 497 Medicaid eligibility of former foster children. (S) Public Law 124 497
SB 495 Medicaid payments for dialysis treatment. (S) First reading: referred to Committee on Health and Provider Services 495
SB 489 Medicaid rate for chemical dependency services. (S) First reading: referred to Committee on Health and Provider Services 489
HB 1393 Administration of human services. (H) First reading: referred to Committee on Family, Children and Human Affairs 1393
SB 396 Guardian reimbursement and Medicaid eligibility. (H) Referred to the Committee on Ways and Means pursuant to House Rule 127 396
HB 1340 Medicaid reimbursement for day services. (H) First reading: referred to Committee on Family, Children and Human Affairs 1340
HB 1392 Access to epilepsy medications. (H) First reading: referred to Committee on Public Health 1392
SB 468 Hospices and Medicaid. (S) First reading: referred to Committee on Health and Provider Services 468
HB 1600 Medicaid eligibility of former foster children. (H) First reading: referred to Committee on Family, Children and Human Affairs 1600
HB 1493 Long term care and home health agencies. (H) Public Law 224 1493
HB 1541 Addiction treatment teams. (H) Public Law 203 1541
HB 1580 Medicaid reimbursement for services for disabilities. (H) First reading: referred to Committee on Family, Children and Human Affairs 1580
HB 1439 FSSA matters. (H) Public Law 152 1439
HB 1572 Medicaid accountable care pilot program. (H) First reading: referred to Committee on Public Health 1572
HB 1337 Telemedicine matters. (H) Public Law 150 1337
HB 1138 Publication of Medicare information. (H) First reading: referred to Committee on Public Health 1138
HB 1150 Prescription drug cost reporting. (H) First reading: referred to Committee on Public Health 1150